Recent Finacing
Recent Raise
Auspherix develops antibiotics with a novel mechanism of action and broad-spectrum activity against multidrug-resistant Gram-negative and Gram-positive pathogens, advancing lead optimization via UK–Australia academic and industry partnerships.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors